Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

15.43
Delayed Data
As of Feb 17
 +0.45 / +3.00%
Today’s Change
9.02
Today|||52-Week Range
16.06
+16.63%
Year-to-Date
No recent news for Insmed Inc.

Today’s Trading

Previous close14.98
Today’s open14.99
Day’s range14.70 - 15.50
Volume320,197
Average volume (3 months)310,318
Market cap$954.8M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)-26.55%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.05-0.66%
ZIOPZIOPHARM Oncology In...+0.05+0.73%
AIMTAimmune Therapeutics...-0.07-0.35%
GBTGlobal Blood Therape...+1.95+7.82%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$0.00
Annual profit (last year)-$118.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Andrew T. Drechsler
Corporate headquarters
Bridgewater, New Jersey

Forecasts


Search for Jobs